The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells

Journal of Nutrition

Volumn 136, Issue 6, 2006, Pages 1528-1532

  Zeng, Huawei ^a   Briske Anderson, Mary ^a   Idso, Joseph P ^a   Hunt, Curtiss D ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cancer; Cell cycle; Invasion; Migration; Selenium

Indexed keywords

METHYLSELENOL; SELENIUM DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL;

EID: 33646822132     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.6.1528     Document Type: Article

References (25)

1. Miki K, Xu M, Gupta A, Ba Y, Tan Y, Al-Refaie W, Bouvet M, Makuuchi M, Moossa AR, Hoffman RM. Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res. 2001;61:6805-10.
2. Combs GF, Jr. Status of selenium in prostate cancer prevention. Br J Cancer. 2004;91:195-9.
3. Lu J, Jiang C. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Nutr Cancer. 2001;40:64-73.
4. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998;128:1845-54.
5. Davis CD, Zeng H, Finley JW. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 2002;132:307-9.
6. Stadtman TC. Selenocysteine. Annu Rev Biochem. 1996;65:83-100.
7. Zeng H. Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002;132:674-9.
8. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes. Vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.
9. Combs GF Jr., Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998;79:179-92.
10. Clark LC, Combs GF Jr., Turnbull BW, Slate E, Alberts D, Abele D, Allison R, Bradshaw J, Chalker D, et al. The nutritional prevention of cancer with selenium 1983-1993: a randomized clinical trial. JAMA. 1996;276:1957-63.
11. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999;20:1657-66.
12. Liotta L. The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview. Cancer Metastasis Rev. 1990;9:285-7.
13. Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, et al. A phosphatase associated with metastasis of colorectal cancer. Science. 2001;294:1343-6.
14. Chen TR. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977;104:255-62.
15. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med. 1998;49:407-24.
16. Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 1999;20:749-55.
17. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-32.
18. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 1990;9:289-303.
19. Loukopoulos P, Mungall BA, Straw RC, Thornton JR, Robinson WF. Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet Pathol. 2003;40:382-94.
20. Oba K, Konno H, Tanaka T, Baba M, Kamiya K, Ohta M, Kaneko T, Shouji T, Igarashi A, Nakamura S. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett. 2002;175:45-51.
21. Esaki N, Tanaka H, Uemura S, Suzuki T, Soda K. Catalytic action of L-methionine gamma-lyase on selenomethionine and selenols. Biochemistry. 1979;18:407-10.
22. Wang Z, Jiang C, Lu J. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol. Mol Carcinog. 2002;34:113-20.
23. Laquerriere P, Grandjean-Laquerriere A, Addadi-Rebbah S, Jallot E, Laurent-Maquin D, Frayssinet P, Guenounou M. MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles. Biomaterials. 2004;25:2515-24.
24. Hoegy SE, Oh HR, Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem. 2001;276:3203-14.
25. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114:171-80.